Skip to content
Search

Latest Stories

Air pollution linked to increased antibiotic resistance: Study

Evidence suggests air pollution contributes to the spread of antibiotic-resistant bacteria and resistance genes

Air pollution linked to increased antibiotic resistance: Study

New research published in The Lancet Planetary Health journal suggests that the mitigation of air pollution could potentially contribute to the reduction of antibiotic resistance.

The study indicates that addressing air pollution may play a role in countering the phenomenon where disease-causing microorganisms develop resistance to antibiotics, rendering these drugs less effective.


The association between PM2.5 air pollution and an increase in antibiotic resistance has strengthened over time, with enhances in PM2.5 levels leading to larger increases in antibiotic resistance in more recent years, the analysis found using data for 116 countries from 2000 to 2018.

PM stands for "particulate matter" or microscopic particles. The term refers to tiny particles suspended in the air, including pollutants such as dust, soot, smoke, and other fine particles.

The number "2.5" in "PM2.5" refers to the particle size, specifically particles with a diameter of 2.5 micrometres or smaller.

PM2.5 particles are particularly concerning due to their small size, which allows them to be easily inhaled and potentially reach deep into the respiratory system and even the bloodstream, posing health risks.

Sources of PM2.5 include industrial processes, road transport, and domestic coal and wood burning.

Previous research indicates 90 per cent of the world's population, or 7.3 billion people, are directly exposed to unsafe average annual PM2.5 levels, with 80 per cent of them living in low-and middle-income countries.

PM2.5 air pollution was one of the leading factors driving antibiotic resistance, accounting for 11 per cent of changes in average antibiotic resistance levels globally, this study found.

Further, every 1 per cent rise in air pollution was linked with an increase in antibiotic resistance of between 0.5 and 1.9 per cent, depending on the pathogen, or the disease-causing microbe, the study covering nine bacterial pathogens and 43 types of antibiotics found.

The highest levels of antibiotic resistance were found to be in North Africa, the Middle East and South Asia, while levels in Europe and North America were found to be low.

Misuse and overuse of antibiotics still remain the main drivers of antibiotic resistance.

However, evidence suggests air pollution also contributes to the spread of antibiotic-resistant bacteria and resistance genes, the study said.

PM2.5 air pollution-driven antibiotic resistance was also linked to an estimated 480,000 premature deaths in 2018, leading to additional economic costs of USD395 billion, the analysis said.

Owing to their huge populations, India and China are expected to face the greatest impact of PM2.5 changes on premature death toll from antibiotic resistance.

By 2050, levels of antibiotic resistance worldwide could increase by 17 per cent under no changes to current air pollution policies, the authors' modelling suggested.

India is expected to experience a 2.5 per cent increase in antibiotic resistance resulting from a 10 per cent increase in yearly PM2.5 levels.

In other scenarios, such as increased health spending, controlling air pollution, improving drinking water and reducing antibiotic usage, the level of antibiotic resistance could be greatly reduced, the study said.

For example, limiting PM2.5 to 5 micrograms per cubic metres in the atmosphere (recommended by the World Health Organization) could decrease global antibiotic resistance by 17 per cent by 2050. It could further reduce premature deaths linked to antibiotic resistance by 23 per cent and save USD 640 billion annually, the study said.

"Antibiotic resistance and air pollution are each in their own right among the greatest threats to global health. Until now, we didn't have a clear picture of the possible links between the two, but this work suggests the benefits of controlling air pollution could be two-fold: not only will it reduce the harmful effects of poor air quality, it could also play a major role in combatting the rise and spread of antibiotic-resistant bacteria," said lead author Hong Chen, Zhejiang University, China.

Future research should investigate underlying mechanisms of how air pollutants impact antibiotic resistance, the study said.

(With inputs from PTI)

More For You

Prada 2026 sandals

Prada acknowledges Indian influence behind its Spring Summer 2026 men’s footwear

Instagram/prada/iStock

Prada finally acknowledges Kolhapuri chappals inspired 2026 sandals after Indian backlash over Milan show

Quick highlights:

• Prada confirms Indian roots behind 2026 ‘leather sandals’ after controversy
• Indian artisans and officials accused the brand of cultural appropriation
• The footwear resembles traditional Kolhapuri chappals with GI status
• Prada says designs are still in development and open to dialogue with India

Keep ReadingShow less
Anna Wintour

Wintour’s style of leadership earned her the nickname “Nuclear Wintour”

Getty Images

Anna Wintour steps down as editor of US Vogue after 37 years

Key points

  • Anna Wintour steps down as editor of US Vogue after 37 years
  • She will remain Vogue’s global editorial director and hold senior roles at Condé Nast
  • Wintour transformed US Vogue into a global fashion authority
  • The 75-year-old has received numerous honours, including the Presidential Medal of Freedom

End of an era at US Vogue

Anna Wintour has stepped down as the editor of US Vogue, bringing to a close a 37-year tenure that redefined the publication and saw her become one of the most influential figures in global fashion.

The announcement was made on Thursday (26 June) during a staff meeting in New York. Wintour, 75, will no longer oversee the day-to-day editorial operations of Vogue’s US edition. However, she will continue to serve as Vogue’s global editorial director and Condé Nast’s chief content officer, maintaining senior leadership roles across the company.

Keep ReadingShow less
Nadiya Hussain

She also reassured her followers that “exciting” new projects are on the way

Getty Images

“I won’t always be grateful” says Nadiya Hussain after BBC axes her cookery show

Key points

  • Nadiya Hussain confirms BBC will not renew her cookery series
  • Bake Off winner challenges expectations to remain “grateful”
  • She says hard work and talent, not luck, brought her success
  • Celebrities, including Annie Lennox and Fearne Cotton, show support

BBC ends decade-long collaboration with Bake Off star

Nadiya Hussain has spoken out after the BBC decided not to commission another cookery programme with her. The popular TV chef, who won The Great British Bake Off in 2015, shared her views on social media, stating that she “won’t always be grateful” and should not be expected to remain silent about career setbacks.

The decision ends a nearly 10-year working relationship between the broadcaster and Hussain, who has hosted several well-received cookery shows under the BBC banner. In her latest Instagram video, she addressed the public’s reaction and emphasised her right to expect more from her career.

Keep ReadingShow less
weight loss injections UK

The importance of vigilance as demand for these weight loss and diabetes drugs continues to grow

iStock

Hundreds report pancreas issues linked to weight loss injections as UK launches safety study

Key points

  • Almost 400 reports of acute pancreatitis linked to weight loss and diabetes jabs have been filed in the UK
  • Most cases involve popular GLP-1 drugs including Ozempic, Wegovy, and Mounjaro
  • Health officials are investigating possible genetic causes behind the side-effects
  • Patients hospitalised with pancreatitis encouraged to report symptoms via MHRA’s Yellow Card scheme
  • Adverse drug reactions cost the NHS an estimated £2.2bn annually

Health watchdog investigates spike in serious side-effects from GLP-1 drugs

UK health authorities have launched a study into the side effects of popular weight loss and diabetes drugs following a spike in reported cases of acute pancreatitis. Nearly 400 reports have been received via the Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, which monitors side effects and adverse reactions related to medicines and medical devices.

The medicines involved are GLP-1 receptor agonists – including semaglutide (marketed as Ozempic and Wegovy), liraglutide, and tirzepatide (branded as Mounjaro). The Yellow Card data shows that 181 of the cases involved tirzepatide alone.

Keep ReadingShow less
M&S launches strawberries

M&S’s latest offering taps into both tradition and innovation

The Wire

M&S launches strawberries and cream sandwich ahead of Wimbledon

Summary

  • M&S unveils limited edition strawberries and cream sandwich for £2.80
  • Inspired by Japanese 'sweet sandos', it features Red Diamond strawberries and whipped cream cheese
  • Available in stores now, found in the savoury sandwich aisle
  • Launch coincides with Wimbledon and British strawberry season
  • Wimbledon increases strawberries and cream price for first time in 15 years

New summer sandwich from M&S

Marks & Spencer has launched a limited edition M&S strawberry sandwich, combining classic British summer flavours with a Japanese twist. Priced at £2.80, the strawberries and cream sandwich is available in M&S stores now.

The dessert-style sandwich features M&S’s exclusive Red Diamond strawberries, whipped cream cheese, and sweetened bread. Despite its sweet contents, the product is found in the savoury sandwich section of M&S Food halls.

Keep ReadingShow less